Walter Reinisch (W Reinisch)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 46

Top Topics

Ulcerative Colitis

Top Venues

Journal of Crohn's & colitis

Alimentary pharmacology & therapeutics

Digestive diseases and sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, Julian Panés, Stefan Schreiber, Walter Reinisch, Brian G Feagan, Silvio Danese, Andres J Yarur, Geert R D'Haens, Martina Goetsch, Karolina Wosik, Michael Keating, Krisztina Lazin, Joseph Wu, Irene Modesto, Aoibhinn McDonnell, Lauren Bartolome, Séverine Vermeire
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme. Journal of Crohn's & colitis (2024)
L Peyrin-Biroulet, P Bossuyt, D Bettenworth, E V Loftus, S I Anjie, G D'Haens, M Saruta, P Arkkila, H Park, D Choi, D- H Kim, Walter Reinisch
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis. Digestive diseases and sciences 69 (5) (2024)
Neeraj Narula, Hasan Hamam, Jasmine Liu, Emily Chu Lee Wong, John K Marshall, Vipul Jairath, Stephen B Hanauer, Walter Reinisch, Parambir S Dulai
Adaptive steroid tapering impedes corticosteroid-free remissions compared to forced tapering in clinical trials of ulcerative colitis. Journal of Crohn's & colitis (2024)
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, Julian Panes, Stefan Schreiber, Walter Reinisch, Brian G Feagan, Silvio Danese, Andres J Yarur, Geert R A M D'Haens, Martina Goetsch, Karolina Wosik, Michael Keating, Krisztina Lazin, Joseph Wu, Irene Modesto, Aoibhinn McDonnell, Lauren Bartolome, Severine Vermeire
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme. Journal of Crohn's & colitis 18 (8) (2024)
Walter Reinisch, Jean-Frederic Colombel, Geert R A M D'Haens, Jordi Rimola, Tomasz Masior, Matt McKevitt, Xuehan Ren, Adrian Serone, David A Schwartz, Krisztina B Gecse
Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial. Journal of Crohn's & colitis 18 (6) (2024)
Walter Reinisch, Jean-Frederic Colombel, Geert R A M D'Haens, Jordi Rimola, Tomasz Masior, Matt McKevitt, Xuehan Ren, Adrian Serone, David A Schwartz, Krisztina B Gecse
Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial. Journal of Crohn's & colitis 18 (6) (2024)
David T Rubin, Joanna Torres, Miguel Regueiro, Walter Reinisch, Lani Prideaux, Paulo G Kotze, Fiona H Tan, Sean Gardiner, Rajiv Mundayat, Mary Jane Cadatal, Siew C Ng
Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis. Crohn's & colitis 360 6 (1) (2024)
Walter Reinisch, Jean-Frederic Colombel, Geert R A M D'Haens, Jordi Rimola, Tomasz Masior, Matt McKevitt, Xuehan Ren, Adrian Serone, David A Schwartz, Krisztina B Gecse
Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial. Journal of Crohn's & colitis 18 (6) (2024)
Nassim Hammoudi, David Sachar, Geert D'Haens, Walter Reinisch, Paulo Gustavo Kotze, Severine Vermeire, Jürgen Schölmerich, Michael A Kamm, Anne M Griffiths, Julian Panes, Subrata Ghosh, Corey Allan Siegel, Willem Bemelman, Colm O'Morain, Flavio Steinwurz, Phillip Fleshner, Gerassimos J Mantzaris, Bruce Sands, Maria T Abreu, Iris Dotan, Dan Turner, Axel Dignass, Matthieu Allez
Outcomes and Endpoints of Postoperative Recurrence in Crohn's Disease: Systematic Review and Consensus Conference. Journal of Crohn's & colitis 18 (6) (2024)
Walter Reinisch, Jean-Frederic Colombel, Geert R D'Haens, Jordi Rimola, Tomasz Masior, Matt McKevitt, Xuehan Ren, Adrian Serone, David A Schwartz, Krisztina B Gecse
Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulizing Crohn's Disease [DIVERGENCE 2]: a Phase 2, Randomized, Placebo-Controlled Trial. Journal of Crohn's & colitis (2024)
L Peyrin-Biroulet, P Bossuyt, D Bettenworth, E V Loftus, S I Anjie, G D'Haens, M Saruta, P Arkkila, H Park, D Choi, D- H Kim, Walter Reinisch
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis. Digestive diseases and sciences (2024)
Sunil Sadruddin Samnani, Emily Chu Lee Wong, Hasan Hamam, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Outcomes of patients with prior biologic intolerance are better than those with biologic failure in clinical trials of inflammatory bowel disease. Journal of Crohn's & colitis (2024)
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, Julian Panés, Stefan Schreiber, Walter Reinisch, Brian G Feagan, Silvio Danese, Andres J Yarur, Geert R D'Haens, Martina Goetsch, Karolina Wosik, Michael Keating, Krisztina Lazin, Joseph Wu, Irene Modesto, Aoibhinn McDonnell, Lauren Bartolome, Séverine Vermeire
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme. Journal of Crohn's & colitis (2024)
L Peyrin-Biroulet, P Bossuyt, D Bettenworth, E V Loftus, S I Anjie, G D'Haens, M Saruta, P Arkkila, H Park, D Choi, D- H Kim, Walter Reinisch
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis. Digestive diseases and sciences 69 (5) (2024)
L Peyrin-Biroulet, P Bossuyt, D Bettenworth, E V Loftus, S I Anjie, G D'Haens, M Saruta, P Arkkila, H Park, D Choi, D- H Kim, Walter Reinisch
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis. Digestive diseases and sciences 69 (5) (2024)
Nassim Hammoudi, David Sachar, Geert D'Haens, Walter Reinisch, Paulo Gustavo Kotze, Severine Vermeire, Jürgen Schölmerich, Michael A Kamm, Anne M Griffiths, Julian Panes, Subrata Ghosh, Corey Allan Siegel, Willem Bemelman, Colm O'Morain, Flavio Steinwurz, Phillip Fleshner, Gerassimos J Mantzaris, Bruce Sands, Maria T Abreu, Iris Dotan, Dan Turner, Axel Dignass, Matthieu Allez
Outcomes and Endpoints of Postoperative Recurrence in Crohn's Disease: Systematic Review and Consensus Conference. Journal of Crohn's & colitis 18 (6) (2024)
David T Rubin, Joanna Torres, Miguel Regueiro, Walter Reinisch, Lani Prideaux, Paulo G Kotze, Fiona H Tan, Sean Gardiner, Rajiv Mundayat, Mary Jane Cadatal, Siew C Ng
Association Between Smoking Status and the Efficacy and Safety of Tofacitinib in Patients with Ulcerative Colitis. Crohn's & colitis 360 6 (1) (2024)
L Peyrin-Biroulet, P Bossuyt, D Bettenworth, E V Loftus, S I Anjie, G D'Haens, M Saruta, P Arkkila, H Park, D Choi, D- H Kim, Walter Reinisch
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis. Digestive diseases and sciences 69 (5) (2024)
L Peyrin-Biroulet, P Bossuyt, D Bettenworth, E V Loftus, S I Anjie, G D'Haens, M Saruta, P Arkkila, H Park, D Choi, D- H Kim, Walter Reinisch
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis. Digestive diseases and sciences 69 (5) (2024)
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, Julian Panes, Stefan Schreiber, Walter Reinisch, Brian G Feagan, Silvio Danese, Andres J Yarur, Geert R A M D'Haens, Martina Goetsch, Karolina Wosik, Michael Keating, Krisztina Lazin, Joseph Wu, Irene Modesto, Aoibhinn McDonnell, Lauren Bartolome, Severine Vermeire
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme. Journal of Crohn's & colitis 18 (8) (2024)
Cindy L J Weinstein, Alan G Meehan, Marinella Govoni, Jianxin Lin, Walter Reinisch
Low Occurrence of Colectomy With Long-Term (up to 4 Years) Golimumab Treatment in Patients With Moderate-to-Severe Active Ulcerative Colitis: Data From the PURSUIT Maintenance and Long-Term Extension Studies. Crohn's & colitis 360 5 (3) (2023)
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics (2023)
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 57 (7) (2023)
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics (2023)
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 57 (7) (2023)
Nassim Hammoudi, David Sachar, Geert D'Haens, Walter Reinisch, Paulo Gustavo Kotze, Severine Vermeire, Jürgen Schölmerich, Michael A Kamm, Anne M Griffiths, Julian Panes, Subrata Ghosh, Corey Allan Siegel, Willem Bemelman, Colm O'Morain, Flavio Steinwurz, Phillip Fleshner, Gerassimos J Mantzaris, Bruce Sands, Maria T Abreu, Iris Dotan, Dan Turner, Axel Dignass, Matthieu Allez, null null
Outcomes and endpoints of postoperative recurrence in Crohn's Disease: systematic review and consensus conference. Journal of Crohn's & colitis (2023)
Martina Scharitzer, Andrea Beer, Thomas Mang, Lukas Walter Unger, Alexander R Haug, Walter Reinisch, Michael Weber, Thomas Nakuz, Lukas Nics, Marcus Hacker, Michael M Bergmann, Sazan Rasul
Evaluation of Intestinal Fibrosis with 68 Ga-FAPI PET/MR Enterography in Crohn Disease. Radiology (2023)
Andreas Blesl, Andrea Borenich, Hans Peter Gröchenig, Gottfried Novacek, Christian Primas, Walter Reinisch, Maximilian Kutschera, Constanze Illiasch, Barbara Hennlich, Pius Steiner, Robert Koch, Wolfgang Tillinger, Thomas Haas, Gerhard Reicht, Andreas Mayer, Othmar Ludwiczek, Wolfgang Miehsler, Karin Steidl, Lukas Binder, Franziska Baumann-Durchschein, Stefan Fürst, Simon Reider, Christina Watschinger, Heimo Wenzl, Alexander Moschen, Andrea Berghold, Christoph Högenauer, null null
Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial. Journal of clinical medicine 12 (14) (2023)
Walter Reinisch, Vivek Pradhan, Saira Ahmad, Zhen Zhang, Jeremy D Gale
Alternative endoscopy reading paradigms determine score reliability and effect size in ulcerative colitis. Journal of Crohn's & colitis (2023)
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 57 (7) (2023)
Sophie Vieujean, James O Lindsay, Ferdinando D'Amico, Vineet Ahuja, Mark S Silverberg, Ajit Sood, Jesus K Yamamoto-Furusho, Masakazu Nagahori, Mamoru Watanabe, Ioannis E Koutroubakis, Kalliopi Foteinogiannopoulou, Irit Avni Biron, Alissa Walsh, An Outtier, Rie Louise Møller Nordestgaard, Maria T Abreu, Marla Dubinsky, Corey Allan Siegel, Edouard Louis, Iris Dotan, Walter Reinisch, Silvio Danese, David T Rubin, Laurent Peyrin-Biroulet
Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases (IBD): Real World Results from the International Organization for the study of IBD. Journal of Crohn's & colitis (2023)
Geert R A M D'Haens, Walter Reinisch, Stefan Schreiber, Fraser Cummings, Peter M Irving, Byong Duk Ye, Dong-Hyeon Kim, Sangwook Yoon, Shomron Ben-Horin
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial. Clinical drug investigation (2023)
Nabeel Khan, Nadim Mahmud, Manthankumar Patel, Ramaswamy Sundararajan, Walter Reinisch
Risk of severe and opportunistic infections and the impact of SARS-COV-2 on this risk in a nationwide cohort of patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 57 (7) (2023)
Séverine Vermeire, Silvio Danese, William J Sandborn, Stefan Schreiber, Stephen Hanauer, Geert D'Haens, Peter Nagy, Manoj Thakur, Caleb Bliss, Fabio Cataldi, Martina Goetsch, Kenneth J Gorelick, Walter Reinisch
Efficacy and Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease. Journal of Crohn's & colitis (2023)
Maximilian Kutschera, Valentin Ritschl, Berthold Reichardt, Tanja Alexandra Stamm, Hans Kiener, Harald Maier, Walter Reinisch, Bernhard Benka, Gottfried Novacek
Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study. Journal of clinical medicine 11 (18) (2022)
Emily Chu Lee Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Editorial: is it not just PROs, but the most important individual PRO, that really matters in Crohn's disease? Authors' reply. Alimentary pharmacology & therapeutics 55 (8) (2022)
Christian Primas, Walter Reinisch, John Carl Panetta, Alexander Eser, Diane R Mould, Thierry Dervieux
Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases. Journal of clinical medicine 11 (12) (2022)
Julian Panes, James O Lindsay, Niels Teich, Stefan Lindgren, Jean Frederic Colombel, Heather Ann Flynn, Susan Huyck, Ruji Yao, George Philip, Walter Reinisch
Colectomy Incidence Rates in Five-Year Data From the Observational Postmarketing Ulcerative Colitis Study of Originator Infliximab. Inflammatory bowel diseases 27 (12) (2022)
Emily Chu Lee Wong, Parambir S Dulai, John K Marshall, Vipul Jairath, Walter Reinisch, Neeraj Narula
Resolution of dominant patient-reported outcome at end of induction predicts clinical and endoscopic remission in Crohn's disease. Alimentary pharmacology & therapeutics 55 (9) (2022)
Brian G Feagan, Reena Khanna, William J Sandborn, Séverine Vermeire, Walter Reinisch, Chinyu Su, Leonardo Salese, Haiyun Fan, Jerome Paulissen, Deborah A Woodworth, Wojciech Niezychowski, Bruce E Sands
Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials. Alimentary pharmacology & therapeutics 54 (11-12) (2021)
Nabeel Khan, Nadim Mahmud, Chinmay Trivedi, Walter Reinisch, James D Lewis
Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System. Gut 70 (9) (2021)
Manuel Muñoz, Walter Reinisch
Letter to the Editor Regarding 'Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland'. Advances in therapy (2021)
Neeraj Narula, Emily Chu Lee Wong, Jean-Frederic Colombel, William J Sandborn, John Kenneth Marshall, Marco Daperno, Walter Reinisch, Parambir S Dulai
Predicting endoscopic remission in Crohn's disease by the modified multiplier SES-CD (MM-SES-CD). Gut (2021)
Ryan C Ungaro, Erica J Brenner, Richard B Gearry, Gilaad G Kaplan, Michele Kissous-Hunt, James D Lewis, William K K Wu, Jean-Francois Rahier, Walter Reinisch, Flávio Steinwurz, Fox E Underwood, Xian Zhang, Jean-Frederic Colombel, Michael D Kappelman
Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut 70 (4) (2020)
Klaus Gottlieb, Marco Daperno, Keith Usiskin, Bruce E Sands, Harris A Ahmad, Colin W Howden, William Karnes, Young S Oh, Irene Modesto, Colleen Marano, Ryan William Stidham, Walter Reinisch
Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments. Gut 70 (2) (2020)
William J Sandborn, Julian Panés, Bruce E Sands, Walter Reinisch, Chinyu Su, Nervin Lawendy, Nana Koram, Haiyun Fan, Thomas V Jones, Irene Modesto, Daniel Quirk, Silvio Danese
Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply. Alimentary pharmacology & therapeutics 51 (11) (2020)